hepatitis b/obesity

Lyen an sove nan clipboard la

Chwazi kalite sòt

Paj 1 soti nan 479 rezilta yo

Thimerosal-containing Hepatitis B Vaccine Exposure is Highly Associated with Childhood Obesity: A Case-control Study Using the Vaccine Safety Datalink.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND Obesity among children and adolescents in the United States has tripled since 1980, and has become a major public health concern. OBJECTIVE The purpose of this study was to evaluate the potential relationship between exposure to organic mercury from Thimerosal-containing hepatitis B

Effect of needle length when immunizing obese adolescents with hepatitis B vaccine.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE Several studies have noted that obese adolescents and adults achieve lower titers of antibody in response to vaccines such as hepatitis B virus (HBV) vaccine. The objective of this study was to determine whether use of a longer (1.5-in) rather than a standard (1-in) needle to penetrate the

Liver resection in hepatitis B-related hepatocellular carcinoma: clinical outcomes and safety in overweight and obese patients.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE Although many studies on evaluating the safety of liver resection in obese patients have been conducted, the results remain contradictory. The aim of our study was to investigate the safety of overweight and obese patients undergoing liver resection for hepatitis B-related hepatocellular

Seroconvertion to hepatitis B vaccine after weight reduction in obese non-responder.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Decreased responses to hepatitis B vaccine have been associated with some host conditions including obesity. Susceptible non-responders to a primary three-dose vaccine series should be revaccinated. Those who maintain a non-responder condition after revaccination with three vaccine doses are

Zeaxanthin dipalmitate alleviates hepatic injury induced by superimposed chronic hepatitis B and non-alcoholic steatohepatitis in non-obese mice.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

A hepatitis B virus (HBV) transgenic mice model was used to establish the fatty liver superimposed model by feeding the methionine choline-deficient (MCD) diet for 8 weeks, with or without the gavage of 2 mg/kg zeaxanthin dipalmitate (ZD) three times per week. Both wild-type and HBV transgenic mice,

Serum adiponectin levels are associated with hepatitis B viral load in overweight to obese hepatitis B virus carriers.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE This study aimed to investigate the association between serum adiponectin and chronic hepatitis B virus (HBV) infection. METHODS We conducted a campus-based cross-sectional study in Northern Taiwan, an HBV-endemic country. A total of 506 participants, including 147 chronic HBV-infected

Obesity and diabetic hyperglycemia were associated with serum alanine aminotransferase activity in patients with hepatitis B infection.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Several studies have reported that obesity and diabetes are important risk factors for elevated blood aminotransferase activity in individuals with no underlying causes of liver disease. The aim of this study was to determine whether obesity and fasting glucose level were associated with hepatic

Occult hepatitis B virus infection predicts non-alcoholic steatohepatitis in severely obese individuals from Italy.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Obesity is associated with non-alcoholic fatty liver (NAFL), which may progress towards non-alcoholic steatohepatitis (NASH), cirrhosis and hepatocellular carcinoma (HCC). Occult hepatitis B virus infection (OBI) may contribute to hepatic damage in patients with chronic liver disease

Impact of weight reduction program on serum alanine aminotransferase activity and immunologic response in obese hepatitis B patients.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND Globally, chronic B viral hepatitis (HBV) is a major health problem. Obesity is a common problem among patients with HBV. Several studies have reported that obesity is an important risk factor that alters immune system response in individuals with no underlying cause of liver disease.

Clinical characteristics and outcome of morbidly obese bariatric patients with concurrent hepatitis B viral infection.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND Bariatric surgery is the only effective and long-lasting treatment of morbidly obese patients. However, the safety and efficacy of bariatric surgery in patients with hepatitis B viral (HBV) infection is not clear. The aim of the present study is to investigate whether HBV infection

Clinical impacts of hazardous alcohol use and obesity on the outcome of entecavir therapy in treatment-naïve patients with chronic hepatitis B infection.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE The aim of this study was to analyze the clinical impacts of obesity and hazardous alcohol use on the outcome of entecavir (ETV) therapy in chronic hepatitis B (CHB) patients. METHODS The medical records of 88 treatment-naïve patients who were diagnosed with CHB and received ETV between

Obesity and hepatocellular carcinoma in patients receiving entecavir for chronic hepatitis B.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE This study aimed to clarify the effect of obesity on the development of hepatocellular carcinoma (HCC) in chronic hepatitis B (CHB) patients receiving antiviral treatment. METHODS This study applied a retrospective analysis to a historical cohort in Bundang Jesaeng Hospital. In total, 102

Obesity and hepatitis B infection are associated with increased risk of metabolic syndrome in university freshmen.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE To investigate the prevalence of metabolic syndrome and its associated risk factors in a cohort of university freshmen. METHODS A cross-sectional study in a university health center in North Taiwan. METHODS A total of 8226 students (mean age: 19.2+/-2.3 years) receiving pre-entrance health

Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Factors associated with lack of antibody response to the hepatitis B virus plasma vaccine were retrospectively evaluated by means of a logistic regression in 194 previously seronegative staff members of a community hospital. All subjects had received three doses of vaccine by intramuscular buttock

Association between obesity, hypertriglyceridemia and low hepatitis B viral load.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE This study aimed to investigate the metabolic risk factors of high hepatitis B viral load. METHODS Large-scale, community-based cross-sectional study. METHODS A total of 3587 hepatitis B virus (HBV)-infected participants without liver cirrhosis at study entry were investigated. High HBV

Antre nan paj
facebook nou an

Herbal & Natural Medicine

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

Travay nan 55 lang
Geri èrbal te apiye nan syans
Remèd fèy rekonesans pa imaj
Kat entèaktif GPS - tag zèb sou kote (vini byento)
Li piblikasyon syantifik ki gen rapò ak rechèch ou an
Search remèd fèy medsin pa efè yo
Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye